Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine vs Dexamethasone for PONV in Laparoscopic Cholecystectomy
NCT07426081Phase 3Completed
- Sponsor
- Patel Hospital
- Start
- Jun 2025
- Primary completion
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of dexmedetomidine in postoperative nausea and vomiting (PONV) (2 arms), sponsored by Patel Hospital. Primary endpoint: Postoperative Nausea and Vomiting score at 24 hours. Started Jun 2025; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on NCT07426081.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07426081.